Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PMI | Ann:Pegmont Quarterly Report 30 June 2025rt rt | 17/07/25 | 0 | 144 | |||
|
|||||||
PMI | Ann:Results of 2025 AGM | 29/05/25 | 0 | 302 | |||
|
|||||||
PMI | Ann:Chairman's Address | 22/05/25 | 0 | 393 | |||
|
|||||||
PMI | Ann:noice of annual general meeing | 28/04/25 | 0 | 270 | |||
|
|||||||
PMI | Ann:Proxy Form | 28/04/25 | 0 | 319 | |||
|
|||||||
PMI | Ann:Quarterly Report Pegmont 31 March 2025 | 28/04/25 | 0 | 272 | |||
|
|||||||
PMI | Ann:Initial Director's Interest notice | 24/03/25 | 0 | 330 | |||
|
|||||||
PMI | Ann:Appointment of Director Wally McDonald | 17/03/25 | 0 | 282 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |